Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
StemoniX announced the opening of its new, state-of-the-art research & development (R&D) facility in La Jolla, CA.
read more
Charles River Laboratories announced the planned opening of the Charles River Accelerator and Development Lab (CRADL™) in South San Francisco in early 2020.
read more
Onyx Scientific has made a strategic investment to position the company for a commercial API license.
read more
Lannett announced it has entered into a future exclusive supply and distribution agreement for the approved Levothyroxine Sodium Tablets USP.
read more
PHARMASEAL has announced a second major release of its Engility CTMS platform.
read more
AmerisourceBergen has entered a long-term strategic relationship with OneOncology, the national partnership of community oncologists driving the future of cancer care in the U.S.
read more
Ligand and SQ Innovation announced a long-term, exclusive commercial license and supply agreements for use of Ligand’s Captisol® technology in the formulation of high-concentration furosemide.
read more
Takeda has officially opened a new manufacturing plant at its site at Grange Castle, in Dublin, Ireland.
read more
The Wasdell Group announced its new state-of-the-art facility in Dundalk, Ireland has received its MIA from the Health Products Regulatory Authority (HPRA).
read more
ZYUS Life Sciences announced it has entered into a definitive agreement to acquire the Kentucky-based healthcare technology company Revon Systems in a share for share transaction.
read more
Crescita has received the second installment of the up-front payment related to the out-licensing of Pliaglis in Italy, France, Spain and Portugal, from its partner, Cantabria Labs.
read more
BioInvent announced it will receive a $0.5 million milestone payment related to the acceptance by the FDA of the IND application for TAK-169, a first-in-class CD38-targeted fusion protein.
read more
Onco360® announced it has been selected as a specialty pharmacy network partner for Karyopharm’s new product XPOVIO™ (selinexor).
read more
Luminex announced the company submitted the ARIES® MRSA Assay to the U.S. Food and Drug Administration (FDA) for clearance.
read more
ALTEN Calsoft Labs has launched – "BioPharma Ledger," a Blockchain clinical trial platform.
read more